Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Additional Information
- This is a methods‑based proficiency challenge for laboratories performing targeted next‑generation sequencing of cancer genes or mutation hotspots in solid tumors.
- This program includes variants present with a variant allele fraction (VAF) potentially as low as 5%.
- Paired normal specimen provided
Program Information
- One 1.0‑μg gDNA (50 ng/μL) paired normal specimen
- Three 1.0‑μg gDNA (50 ng/μL)
Shipping Schedule
-
Shipment A: May 26
-
Shipment B: November 23
Help